We are live on
!
Find out more
CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Est. Return
135.57%
This Fund
S&P 500
This Quarter
Est. Return
-4.59%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
-$1.93B
(-14%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
339
New
69
Increased
77
Reduced
126
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$110M |
| 2 |
Eli Lilly
LLY
|
+$83.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$79.7M |
| 4 |
PayPal
PYPL
|
+$78.7M |
| 5 |
Masco
MAS
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$171M |
| 2 |
Kohl's
KSS
|
+$156M |
| 3 |
Biogen
BIIB
|
+$150M |
| 4 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$79.6M |
| 5 |
Viatris
VTRS
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.35% |
| 2 | Consumer Discretionary | 22.13% |
| 3 | Technology | 18.35% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
8x8 Inc
EGHT
$328M
| $928K | 0.01% |
112,199
+17,376
| +18% | +$144K |
|
252
Synaptics
SYNA
$4.14B
| $905K | 0.01% |
+10,970
| New | +$829K |
|
253
Moody's
MCO
$83.2B
| $884K | 0.01% |
9,000
-8,800
| -49% | -$936K |
|
|
CSOD
254
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $814K | 0.01% |
+24,674
| New | +$900K |
|
255
Neogen
NEOG
$2.48B
| $788K | 0.01% |
+46,699
| New | +$919K |
|
|
RVNC
256
DELISTED
Revance Therapeutics, Inc.
RVNC
| $761K | 0.01% |
25,561
+4,338
| +20% | +$132K |
|
257
Analog Devices
ADI
$189B
| $740K | 0.01% |
13,112
-2,068
| -14% | -$120K |
|
258
Bread Financial
BFH
$4.38B
| $718K | 0.01% |
+3,472
| New | +$750K |
|
259
MACOM Technology Solutions
MTSI
$23.3B
| $707K | 0.01% |
+24,390
| New | +$769K |
|
260
TherapeuticsMD
TXMD
$24M
| $668K | 0.01% |
2,279
-973
| -30% | -$346K |
|
261
Akebia Therapeutics
AKBA
$233M
| $627K | 0.01% |
+64,953
| New | +$596K |
|
|
IPHI
262
DELISTED
INPHI CORPORATION
IPHI
| $615K | 0.01% |
+25,580
| New | +$587K |
|
|
OTIC
263
DELISTED
Otonomy, Inc.
OTIC
| $571K | ﹤0.01% |
+32,055
| New | +$758K |
|
264
Vanda Pharmaceuticals
VNDA
$297M
| $533K | ﹤0.01% |
+47,258
| New | +$578K |
|
|
AZPN
265
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $525K | ﹤0.01% |
+13,839
| New | +$525K |
|
266
Insmed
INSM
$29B
| $470K | ﹤0.01% |
25,293
-2,330
| -8% | -$58.2K |
|
267
uniQure
QURE
$3.2B
| $391K | ﹤0.01% |
19,126
-3,461
| -15% | -$91.2K |
|
|
KIN
268
DELISTED
Kindred Biosciences, Inc.
KIN
| $368K | ﹤0.01% |
70,704
-72,853
| -51% | -$449K |
|
|
BSFT
269
DELISTED
BroadSoft, Inc.
BSFT
| $327K | ﹤0.01% |
+10,930
| New | +$356K |
|
|
OCLR
270
DELISTED
Oclaro Inc.
OCLR
| $294K | ﹤0.01% |
127,650
-19,022
| -13% | -$46.6K |
|
|
ARAV
271
DELISTED
Aravive, Inc. Common Stock
ARAV
| $286K | ﹤0.01% |
+4,138
| New | +$388K |
|
|
HDP
272
DELISTED
Hortonworks, Inc.
HDP
| $216K | ﹤0.01% |
9,888
-17,432
| -64% | -$433K |
|
273
Abbott
ABT
$188B
| – | – |
-569,414
| Closed | -$27.9M |
|
274
Align Technology
ALGN
$12.5B
| – | – |
-413,998
| Closed | -$26M |
|
275
Alkermes
ALKS
$8.23B
| – | – |
-70,620
| Closed | -$4.54M |
|
Similar funds
SWM
LCM
HCMNY
BII
HCM
DBC
DK
AVAX
Columbus Circle Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Columbus Circle Investors held 339 positions worth $12.2B, down 14% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Columbus Circle Investors withdrew a net $880M in Q3 2015, closing 67 positions and reducing 126 holdings. Its most notable exit was Walt Disney, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Columbus Circle Investors opened a new position in TJX Companies worth $112M.
- Columbus Circle Investors's largest Q3 2015 buy was TJX Companies: 3,126,528 shares worth $112M.
- Columbus Circle Investors added most to Eli Lilly in Q3 2015, an estimated $83.1M increase.
- Columbus Circle Investors's biggest Q3 2015 reduction was Biogen, cutting an estimated $150M.
- Columbus Circle Investors fully exited Walt Disney in Q3 2015, selling an estimated $171M.
- Columbus Circle Investors's ten largest holdings make up 24% of its $12.2B portfolio in Q3 2015.
- Columbus Circle Investors opened 69 new positions and closed 67 in Q3 2015.
- Columbus Circle Investors's portfolio value fell 14% quarter-over-quarter to $12.2B.
Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.